Physical Sciences and Engineering Advances in Life Sciences and Oncology
Redigert av Cynthia Reinhart-King, Sharon Gerecht, Ross Levine, Paul Janmey, Parag Mallick, Owen McCarty, Lance Munn, Daniel Fletcher, 2016.Del av serien Science Policy Reports.
A WTEC Global Assessment
This book presents an Assessment of Physical Sciences and Engineering Advances in Life Sciences and Oncology (APHELION) by a panel of experts. It covers the status and trends of applying physical sciences and engineering principles to oncology research in leading laboratories and organizations in Europe and Asia. The book elaborates on the six topics identified by the panel that have the greatest potential to advance understanding and treatment of cancer, each covered by a chapter in the book. The study was sponsored by the National Cancer Institute (NCI) at the National Institute of Health (NIH), the National Science Foundation (NSF) and the National Institute of Biomedical Imaging and Bioengineering at the NIH in the US under a cooperative agreement with the World Technology Evaluation Center (WTEC).
Innbundet — ikke tilgjengelig
Pocket
E-bok — ikke tilgjengelig
Lydbok — ikke tilgjengelig
Språk: Engelsk
Normalpris: 1 249,-
1 124,-
Spar 125,-
Ikke tilgjengelig for Klikk&Hent
Midlertidig utsolgtBestillingsvare. Forventes sendt om ca 20 dager
Physical Sciences and Engineering Advances in Life Sciences and Oncology
Redigert av Cynthia Reinhart-King, Sharon Gerecht, Ross Levine, Paul Janmey, Parag Mallick, Owen McCarty, Lance Munn, Daniel Fletcher, 2016.Del av serien Science Policy Reports.
A WTEC Global Assessment
This book presents an Assessment of Physical Sciences and Engineering Advances in Life Sciences and Oncology (APHELION) by a panel of experts. It covers the status and trends of applying physical sciences and engineering principles to oncology research in leading laboratories and organizations in Europe and Asia. The book elaborates on the six topics identified by the panel that have the greatest potential to advance understanding and treatment of cancer, each covered by a chapter in the book. The study was sponsored by the National Cancer Institute (NCI) at the National Institute of Health (NIH), the National Science Foundation (NSF) and the National Institute of Biomedical Imaging and Bioengineering at the NIH in the US under a cooperative agreement with the World Technology Evaluation Center (WTEC).